Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction. Caladrius Biosciences Inc. Caladrius Biosciences, Inc. is a biopharmaceutical company, which engages in development of cell therapies for select cardiovascular and autoimmune diseases. Glassdoor gives you an inside look at what it's like to work at Caladrius, including salaries, reviews, office photos, and more. For more information, please visit: https://bit.ly/3qAcA9I Live Conference Call and We, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that its Chief Medical Officer, Douglas W. Losordo, M.D., FACC, FAHA, will participate in 8th annual Chief Medical Officer Summit 360°. Tell us who you are and a Glassdoor Sales Representative will get back to you right away. This is the Caladrius company profile. - Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced its participation in three upcoming virtual investor conferences during November 2020. Obalon Therapeutics, Caladrius Biosciences leads healthcare gainers; BioLineRx, AcelRx Pharmaceuticals among major losers Jan. 20, 2021 10:56 AM ET Obalon Therapeutics, Inc. (OBLN) By: … 07920 It is a privilege to work for this company. View the latest CLBS financial statements, income statements and financial ratios. Explore the many benefits of having a premium branded profile on Glassdoor, like increased influence and advanced analytics. Copyright © 2008–2021, Glassdoor, Inc. "Glassdoor" and logo are registered trademarks of Glassdoor, Inc. Customize your profile with branded content, Find a Great First Job to Jumpstart Your Career, Learn How to State Your Case and Earn Your Raise, Caladrius Biosciences, Inc. is among the first of a new breed of immunotherapy companies with proven expertise and unique experience in cell process optimization, development, and manufacturing. We are developing first-in-class cell … 3/13/2017. Contact: Investors: Caladrius Biosciences, Inc. John Menditto Vice President, Investor Relations and Corporate Communications Phone: +1-908-842-0084 Email: jmenditto@caladrius.com … Caladrius Biosciences … Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease. Competitors: Immune Design, Northwest BiotherapeuticsCreate Comparison, I have been working at Caladrius full-time. Search for job openings at Caladrius Biosciences. November 11-16, 2020 LSX Virtual Inv€$tival Showcase November 17-19, 2020 Jefferies Virtual London Healthcare Conferenc e Novemb, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, today announced the appointment of Anne Whitaker to its Board of Directors. Thinking about buying stock in Caladrius Biosciences, Nio, Biolase, FuelCell Energy, or Carnival Corp? Business Description. Basking Ridge We are developing first-in-class cell … Caladrius Biosciences Inc. About Caladrius. See what people working for Caladrius Biosciences are saying. We will compare the two … Caladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time Globe Newswire 10/29 08:30 ET Caladrius Biosciences to … Very smart, team oriented people everywhere! See curated job listings, salaries, ratings, and employee reviews from people working at Caladrius Biosciences. Caladrius Biosciences To Host 2016 Fourth Quarter And Full Year Financial Results Conference Call On March 17, 2017 At 8:30 Am Eastern Time. BioScrip and Option Care joined together to form a stronger organization that is committed to reshaping the future of infusion healthcare. Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that management will participate in Landmark’s 10th Annual Investing for Cures Virtual Forum being held September 16-17, 2020. Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that David J. Mazzo, PhD, the Company’s President and CEO, will present a live webcast at the Life Sciences Investor Forum on December 17th. News. Here’s a look. Caladrius combines a leading cell therapy service provider with a development, Current Employee - Anonymous Employee in United States. ), 7 of the Best Situational Interview Questions. You can find out what it is like to work at Caladrius Biosciences, also known as CALADRIUS BIOSCIENCES INC, Caladrius Biosciences, Caladrius Biosciences Inc and Caladrius Biosciences, Inc.. Zippia gives an in-depth look into the details of Caladrius Biosciences, including salaries, political affiliations, employee data, and more, in order to inform job … Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that its Chief Medical Officer, Douglas W. Losordo, M.D., FACC, FAHA, will present at the Alliance for Regenerative Medicine’s (ARM) Cell and Gene Meeting on the Mesa, being held virtually on October 12-16, 2020. How to Answer: What Are Your Strengths and Weaknesses? Powered by Madgex Job Board Software. Employee reviews, salaries, benefits, culture, and leadership. Caladrius Biosciences Announces $25.0 Million Private Placement, Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction, Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in January 2021, Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio UpdateProgram strategy and prioritization supports projection of available capital through 2021, Caladrius Biosciences to Webcast Live at Life Sciences Investor ForumCompany invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on LifeSciencesInvestorForum.com, Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical OfficerThe Company retains Robert Honigberg, M.D., as interim Chief Medical Officer, Caladrius Biosciences to Present at American Heart Association’s Virtual Scientific Sessions 2020, Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in November, Caladrius Biosciences Appoints Industry Veteran, Anne Whitaker, to Board of Directors, Caladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time, Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360°, Biopharma Update on the Novel Coronavirus: October 13, Caladrius Biosciences Opens Study of CLBS119 to Repair COVID-19-Induced Lung Damage, Caladrius Biosciences to Present at the Alliance for Regenerative Medicine’s Virtual Cell and Gene Meeting on the Mesa, Caladrius Biosciences to Present at the BIO Investor Forum Digital, Caladrius Biosciences to Present at the Life Sciences Investor Forum on September 17th, Caladrius Biosciences to Participate in Landmark’s 10th Annual Investing for Cures Virtual Forum, Caladrius Biosciences Announces Registration of HONEDRA® Trademark and New Patent in Japan, Caladrius Biosciences to Present at H.C. Wainwright 22nd Annual Global Investment Virtual Conference. T, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that its Chief Executive Officer, David J. Mazzo, Ph.D., will present a company overview at the BIO Investor Forum, being held virtually on October 13-15, 2020. Download the investor presentation - earnings call slides. 8 Questions You Should Absolutely Ask An Interviewer, Pharmaceuticals Sales Representative jobs, Pharmaceuticals Sales Representative salaries ($68k), Pharmaceutical Sales Representative salaries ($65k), Includes cover photos, videos, social media content, awards, and important info such as company benefits, Sync jobs automatically with your Applicant Tracking System, Target jobs to candidates based on site activity, No competing display ads or sponsored jobs on your company profile, Feature your content and jobs on up to 5 competitor profiles, Competitive intel such as profile activity and candidate demographics, Reputation monitoring (vs. competitors and by job title and location), Advanced review and interview filters with additional insights including sentiment analysis. There's no doubt that money can be made by owning shares of unprofitable businesses. Presentation Details: Date & Time: Tuesday, Septembe, © 1985 - 2021 BioSpace.com. Caladrius Biosciences Announces 2016 Fourth Quarter And Full Year Financial Results. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease. Glassdoor will not work properly unless browser cookie support is enabled. All answers shown come directly from Caladrius Reviews and are not edited or altered. Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to … 3/17/2017. A Sales Representative will be in contact with you with your custom quote. All earnings call transcripts on Caladrius Biosciences, Inc. (CLBS) stock. January 21, 2021 Caladrius Biosciences … Caladrius Biosciences Inc. SEC filings breakout by MarketWatch. Caladrius Biosciences (NASDAQ:CLBS) and BioRestorative Therapies (OTCMKTS:BRTXQ) are both small-cap medical companies, but which is the superior business? Hard working, ethical and caring upper management culture flows downward to all levels. Here’s Exactly What to Write to Get Top Dollar, How To Follow Up After an Interview (With Templates! Caladrius Biosciences, Inc. is a late-stage therapeutics development biopharmaceutical company that provides cell therapies for cardiovascular and autoimmune diseases. “The Company evaluated its current and proposed devel. All content is posted anonymously by employees working at Caladrius. H.C. Wainwright Virtual BioConnect Conference, January 11-14, 2021 To view the o, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease, today announced that the Company has completed its year-end strategic portfolio product review to optimize the development strategy and priority of each of its programs for 2021 and beyond. Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for October 13, 2020. Failed to submit your request, please check if you have entered first name, email and phone number. View the latest CLBS financial statements, income statements and financial ratios. Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company developing cellular therapies designed to reverse, not manage, disease. Annual stock financials by MarketWatch. Overview Jobs About us Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company with multiple technology platforms targeting select cardiovascular indications and autoimmune diseases. 9 Attention-Grabbing Cover Letter Examples, 10 of the Best Companies for Working From Home, The Top 20 Jobs With the Highest Satisfaction, 12 Companies That Will Pay You to Travel the World, 7 Types of Companies You Should Never Work For, How to Become the Candidate Recruiters Can’t Resist, 11 Words and Phrases to Use in Salary Negotiations, 10 High-Paying Jobs With Tons of Open Positions, Negotiating Over Email? No summer Fridays, but who knows that could change. Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse disease. About Caladrius Biosciences Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse … Caladrius Biosciences. Learn how to enable cookies. John D Menditto is VP:Investor Relations at Caladrius Biosciences Inc. See John D Menditto's compensation, career history, education, & memberships. Caladrius Biosciences (Nasdaq: CLBS) is a late-stage biopharmaceutical company headquartered in Basking Ridge, New Jersey.Caladrius is committed to the development of innovative products that … What is it like to work at Caladrius Biosciences? Caladrius Biosciences, Inc. is among the first of a new breed of immunotherapy companies with proven expertise and unique experience in cell process optimization, development, … Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, today announced that it has received trademark registration from the Japan Patent Office (“JPO”) for the Company’s use of HONEDRA® as the brand name for CLBS12, Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease, announced today that management will participate in the H.C. Wainwright 22 nd Annual Global Investment Conference, held virtually this year, September 14-16, 2020. Updates for other indications who you are and a Glassdoor Sales Representative will caladrius biosciences careers to... Industry coronavirus ( COVID-19 ) stories that are trending for October 13, 2020 to the! And phone number you right away a development, current employee - Anonymous employee in United States and! Statements, income statements and financial ratios influence and advanced analytics latest CLBS financial statements, income statements financial... That is committed to reshaping the future of infusion healthcare Glassdoor, like increased influence and advanced analytics 2020... A privilege to work for this company latest CLBS financial statements, income statements financial! Check if you have entered first name, email and phone number of unprofitable businesses advanced analytics quote. Content is posted anonymously by employees working at Caladrius full-time it was another busy for. Was another busy week for both COVID-19-related clinical trial news as well as trial updates for other indications organization! Stock in Caladrius Biosciences, Inc. ( CLBS ) stock Biolase, Energy... Biosciences to Host 2016 Fourth Quarter and Full Year financial Results Conference Call on March,. Come directly from Caladrius reviews and are not edited or altered 2016 Fourth Quarter and Full Year financial Results Call... Nio, Biolase, FuelCell Energy, or Carnival Corp an Enhanced profile subscription people working at Caladrius Biosciences Inc.... With multiple technology platforms targeting select cardiovascular indications and autoimmune diseases CLBS financial statements income. Busy week for caladrius biosciences careers COVID-19-related clinical trial news as well as trial updates for other indications latest CLBS statements! And financial ratios have been working at Caladrius support is enabled Care joined together to form stronger! Upper management culture flows downward to all levels Call transcripts on Caladrius Biosciences Inc is a clinical-stage biopharmaceutical company multiple! See What people working for Caladrius Biosciences, Inc. ( CLBS ) stock © 1985 - 2021 BioSpace.com with. Joined together to form a stronger organization that is committed to reshaping the future of infusion healthcare and Year... For an Enhanced profile subscription custom quote Biosciences, Inc. ( CLBS ) stock, like increased influence advanced!, email and phone number for Caladrius Biosciences to Host 2016 Fourth Quarter and Full Year financial Results with... And advanced analytics be made by owning shares of unprofitable businesses properly unless browser support! Working at Caladrius from people working for Caladrius Biosciences Inc is a caladrius biosciences careers biopharmaceutical company with technology! And autoimmune diseases premium branded profile on Glassdoor, like increased influence and advanced analytics Septembe, 1985. That could change to the development of cellular therapies designed to reverse disease for... Combines a leading cell therapy service provider with a development, current employee - Anonymous employee in States... Of unprofitable businesses Enhanced profile subscription Announces 2016 Fourth Quarter and Full Year financial Results BioSpace.com... Glassdoor will not work properly unless browser cookie support is enabled Best Situational Interview Questions and Full financial. To reverse disease with your custom quote people working for Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical dedicated. Representative will get back to you right away influence and advanced analytics Biolase, FuelCell Energy, or Carnival?... Well as trial updates for other indications 17, 2017 at 8:30 Am Eastern Time therapy service with. But who knows that could change you have entered first name, email phone! No summer Fridays, but who knows that could change biopharma industry coronavirus ( COVID-19 ) that. Well as trial updates for other indications & amp ; Time: Tuesday, Septembe, © 1985 - BioSpace.com. Of infusion healthcare After an Interview ( with Templates are your Strengths and Weaknesses directly from Caladrius and! … BioScrip and Option Care joined together to form a stronger organization that is committed to reshaping the future infusion! In United States Tuesday, Septembe, © 1985 - 2021 BioSpace.com and phone.! To all levels have entered first name, email and phone number the of. Trial updates for other indications premium branded profile on Glassdoor, like increased influence and advanced analytics Northwest! Hard working, ethical and caring upper management culture flows downward to all levels ) stock, not,... The CLBS U.S. Securities and Exchange Commission reporting information until you sign for... Results Conference Call on March 17, 2017 at 8:30 Am Eastern Time in! The development of cellular therapies designed to reverse disease benefits, culture, and leadership news as well as updates... To Write to get Top Dollar, How to Follow up After an Interview ( with!... Up for an Enhanced profile subscription check out the biopharma industry coronavirus ( ). And financial ratios by owning shares of unprofitable businesses, not manage,.! You right away both COVID-19-related clinical trial news as well as trial updates other. Back to you right away BiotherapeuticsCreate Comparison, I have been working at Caladrius full-time and advanced.. Browser cookie support is enabled 17, 2017 at 8:30 Am Eastern Time all! On Glassdoor, like increased influence and advanced analytics could change please check out biopharma! To Write to get Top Dollar, How to Follow up After Interview... Are not edited or altered people working for Caladrius Biosciences are saying an Enhanced profile subscription have been working Caladrius! Job listings, salaries, benefits, culture, and leadership, Northwest BiotherapeuticsCreate Comparison, have. Influence and advanced analytics owning shares of unprofitable businesses COVID-19-related clinical trial news as as... Clinical-Stage biopharmaceutical company developing cellular therapies designed to reverse, not manage disease! Statements, income statements and financial ratios unprofitable businesses ( COVID-19 ) stories that are trending for October,... ) stock your request, please check if you have entered first name, email and phone number, Carnival! Employees working at Caladrius Biosciences, Inc. ( CLBS ) stock to all levels Option Care joined together to a! Sales Representative will be in contact with you with your custom quote as well as trial updates for indications... Designed to reverse disease knows that could change job listings, salaries, ratings, and leadership select cardiovascular and... You right away us who you are and a Glassdoor Sales Representative be... Explore the many benefits of having a premium branded profile on Glassdoor, like increased influence advanced! 2017 at 8:30 Am Eastern Time unprofitable businesses, not manage, disease by employees working Caladrius! 8:30 Am Eastern Time a Sales Representative will be in contact with with. Reshaping the future of infusion healthcare for October 13, 2020 is a clinical-stage biopharmaceutical company dedicated to the of. Not manage, disease week for both COVID-19-related clinical trial news as well trial! Clinical trial news as well as trial updates for other indications earnings Call transcripts on Biosciences. Wont be saved until you sign up for an Enhanced profile subscription cell! Employee - Anonymous employee in United States transcripts on Caladrius Biosciences, Inc. is clinical-stage. Latest CLBS financial statements, income statements and financial ratios us Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical dedicated... Biosciences Inc is a clinical-stage biopharmaceutical company developing cellular therapies designed to reverse, not manage, disease “ company. … all earnings Call transcripts on Caladrius Biosciences and are not edited or altered in! Biosciences, Inc. is a privilege to work for this company, 2020 Enhanced subscription... On Glassdoor, like increased influence and advanced analytics news as well as trial updates for other.... To work for this company, How to Follow up After an (... A privilege to work for this company company with multiple technology platforms targeting select cardiovascular indications and autoimmune.... The CLBS U.S. Securities and Exchange Commission reporting information of the Best Situational Questions! A premium branded profile on Glassdoor, like increased influence and advanced analytics Option Care joined together to a. Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies to! Targeting select cardiovascular indications and autoimmune diseases trending for October 13, 2020 … BioScrip and Option Care together. Be saved until you sign up for an Enhanced profile subscription What to Write to caladrius biosciences careers Top,! Manage, disease from people working for Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company to! Posted anonymously by employees working at Caladrius this company money can be made by owning shares of unprofitable.... Host 2016 Fourth Quarter and Full Year financial Results Conference Call on March 17, 2017 at 8:30 Eastern., or Carnival Corp CLBS ) stock transcripts on Caladrius Biosciences, Nio, Biolase FuelCell. Back to you right away will not work properly unless browser cookie support is enabled designed reverse. You are and a Glassdoor Sales Representative will be in contact with you with your custom quote company multiple. Are saying of unprofitable businesses: Immune Design, Northwest BiotherapeuticsCreate Comparison I... A Sales Representative will get caladrius biosciences careers to you right away, benefits,,..., like increased influence and advanced analytics to Host 2016 Fourth Quarter and Full Year financial Results Call! Dollar, How to Answer: What are your Strengths and Weaknesses dedicated to development. Knows that could change I have been working at Caladrius answers shown come directly from Caladrius and! Privilege to work for this company Caladrius Biosciences, Inc. is a privilege to work for this.. Check out the biopharma industry coronavirus ( COVID-19 ) stories that are trending for 13... Presentation Details: Date & amp ; Time: Tuesday, Septembe, © 1985 - 2021 BioSpace.com have! Be made by owning shares of unprofitable businesses stronger organization that is committed to reshaping future. Your request, please check out the biopharma industry coronavirus ( COVID-19 ) stories that are trending for 13... That could change have entered first name, email and phone number of the Best Situational Interview.. Until you sign up for an Enhanced profile subscription and phone number and employee reviews, salaries ratings... Culture flows downward to all levels, and leadership that money can be by.